Influenza Update N° 443
Influenza Update N° 442
Communicable disease threats report, Week 13, 26 March - 1 April 2023
Influenza Update N° 440
Communicable disease threats report, week 9, 27 February - 5 March 2023
Possible Undetected Mpox Infection Among Persons ..
Collaborating to Strengthen Surveillance Systems Worldwide | Division of Global Health Protection | Global Health | CDC
H5N1 Update: Two Human H5N1 Cases in Cambodia | Avian Influenza (Flu)
WHO Health and Climate Change Global Survey
Influenza Update N° 439
COVID-19: Pacific Community Updates
Influenza Update N° 438
Multi-country outbreak of mpox, External situation report#15- 2 February 2023
Benefits of Flu Vaccination During 2021-2022 Flu Season
Current U.S. Bird Flu Situation in Humans
Influenza Update N° 437
Update on SARS-CoV-2 variants: ECDC assessment of the XBB.1.5 sub-lineage
Pneumococcal disease infections caused by serotypes not in Prevenar 13 vaccine
Last updated 12/2022 - Summary of Product Characteristics Comirnaty 3 micrograms/dose concentrate for ages 6 months to 4 years (maroon cap)
Performance of lateral flow devices during the COVID-19 pandemic
WHO recommends new name for monkeypox disease
Interim analysis of COVID-19 vaccine effectiveness in healthcare workers, an ECDC multi-country study, May 2021–July 2022
Viral Haemorrhagic Fever including Ebola Virus Disease | Public Health Ontario
Influenza virus characterization - Summary Europe, June 2022
Influenza virus characterization - Summary Europe, July 2022
New Omicron sub-lineage likely to cause further increase in covid-19 cases
COVID-19 Activity in Ontario: Ontario COVID-19 Science Advisory Table Dashboard Indicator Roadmap | Public Health Ontario
Lab Alert: MPXV TNF Receptor Gene Deletion May Lead to False Negative Results with Some MPXV Specific LDTs
Lab Advisory: Variant Influenza Virus Infections
Weekly epidemiological record, 2022, vol. 97, 34 (full issue)
Update on vaccination to protect against monkeypox in England - GOV.UK
WHO R&D Blueprint for Epidemics
Interim statement on COVID-19 vaccination for children
COVID-19 Scientific and Public Health Policy Update – (03 August 2022) – Africa CDC
Preparation and administration of mAb114 for Ebola virus disease (EVD)
Methods for the detection and characterisation of SARS-CoV-2 variants - second update
Monthly operational update on COVID-19 - July 2022
Investigation into monkeypox outbreak in England: technical briefing 2 - GOV.UK
NIOSH Conformity Assessment Letter to Manufacturers (CA 2022-1041-R1) | NPPTL | NIOSH | CDC
Joint Committee on Vaccination and Immunisation (JCVI) updated statement on the COVID-19 vaccination programme for autumn 2022 - GOV.UK
COVID-19 Contact tracing: country experiences and way forward
Updated joint statement from ECDC and EMA on additional booster doses of COVID-19 vaccines
Interim statement on decision-making considerations for the use of variant updated COVID-19 vaccines
Interim statement on the composition of current COVID-19 vaccines
A Safe and Effective Vaccine to Prevent Dengue Is Approved | Division of Vector-Borne Diseases | NCEZID | CDC
COVID-19 vaccines and medicines: updates for April 2022 - GOV.UK
Peer Review Plan For 2022 Hepatitis B Screening and Testing Recs.| CDC
ACIP Update to the Evidence to Recommendations for a 2nd COVID-19 Booster Dose in Adults Ages 50 Years and Older and Immunocompromised Individuals | CDC
Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022
COVID-19: Joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines
Epidemiological update on SARS-CoV-2 Omicron sub-lineages BA.4 and BA.5
Variants: distribution of case data, 6 May 2022
Vaccine update: issue 325, April 2022, flu special edition - GOV.UK
Influenza virus characterisation - Summary Europe, March 2022
Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern
WHO treatment guidelines for drug-resistant tuberculosis, 2016 update
Treatment and pharmaceutical prophylaxis of COVID-19
Scientists pinpoint mechanisms associated with severe COVID-19 blood clotting
National Syndromic Surveillance Program (NSSP) - Technical Updates
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) - Recent Work
Innovative genomic data analysis method leads to the discovery of novel coronavirus families
Malaria vaccine: WHO position paper – March 2022
WHO updates its treatment guidelines to include molnupiravir
Transmission of SARS-CoV-2 from mother to baby is rare, say researchers
Global Advisory Committee on Vaccine Safety (GACVS) review of latest evidence of rare adverse blood coagulation events with AstraZeneca COVID-19 Vaccine (Vaxzevria and Covishield)
Current Bird Flu Situation in Wild Birds
WHO advises that ivermectin only be used to treat COVID-19 within clinical trials
Infection
Guidance for people previously considered clinically extremely vulnerable from COVID-19
Weekly epidemiological update on COVID-19 - 15 March 2022
Weekly operational update on COVID-19 - 15 March 2022
